PLA2R1 and diabetes mellitus: Shorter duration of diabetes (OR = 0.798, P = 0.030), higher eGFR levels (OR = 1.030, P = 0.024), and positive anti-PLA2R antibody (OR = 72.727, P < 0.001) are more likely to be diagnosed as IMN.